GU Cancers Symposium 2014 - An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post-chemotherapy - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Tracy Li, Melissa Thompson, Mary Beth Todd, Margaret K. Yu, Thian San Kheoh, Jianming He, and Ryan Saadi at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 -2014 AA Cost-effectiveness-poster Li thumb

Janssen Global Services, Raritan, NJ; Cornerstone Research Group, Inc., Burlington, ON, Canada; Janssen Research & Development, LLC, Los Angeles, CA; Jassen Global Services, Raritan, NJ

 

email news signup